JP2016501236A5 - - Google Patents

Download PDF

Info

Publication number
JP2016501236A5
JP2016501236A5 JP2015545609A JP2015545609A JP2016501236A5 JP 2016501236 A5 JP2016501236 A5 JP 2016501236A5 JP 2015545609 A JP2015545609 A JP 2015545609A JP 2015545609 A JP2015545609 A JP 2015545609A JP 2016501236 A5 JP2016501236 A5 JP 2016501236A5
Authority
JP
Japan
Prior art keywords
composition
active agent
treated
condition
aqa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015545609A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016501236A (ja
Filing date
Publication date
Priority claimed from US13/694,484 external-priority patent/US8877808B2/en
Application filed filed Critical
Publication of JP2016501236A publication Critical patent/JP2016501236A/ja
Publication of JP2016501236A5 publication Critical patent/JP2016501236A5/ja
Pending legal-status Critical Current

Links

JP2015545609A 2012-12-06 2013-06-21 炎症性皮膚状態の予防および治療のための方法 Pending JP2016501236A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/694,484 US8877808B2 (en) 2012-12-06 2012-12-06 Protection against skin diseases by aurin tricarboxylic acid and its derivatives
US13/694,484 2012-12-06
PCT/CA2013/050488 WO2014085920A1 (en) 2012-12-06 2013-06-21 Methods for preventing and treating inflammatory skin conditions

Publications (2)

Publication Number Publication Date
JP2016501236A JP2016501236A (ja) 2016-01-18
JP2016501236A5 true JP2016501236A5 (enExample) 2016-05-26

Family

ID=50881631

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015545609A Pending JP2016501236A (ja) 2012-12-06 2013-06-21 炎症性皮膚状態の予防および治療のための方法

Country Status (7)

Country Link
US (1) US8877808B2 (enExample)
EP (1) EP2928460B1 (enExample)
JP (1) JP2016501236A (enExample)
KR (1) KR20150090920A (enExample)
CN (1) CN104902886A (enExample)
CA (1) CA2893966C (enExample)
WO (1) WO2014085920A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10588879B2 (en) 2011-08-01 2020-03-17 Aurin Biotech Inc. Treatment of age-related macular degeneration
EP3071543B1 (en) 2013-11-18 2019-10-02 Aurin Biotech Inc. Acetyl salicyclic acid dimers, synthesis thereof, and uses thereof to prevent and treat complement-mediated disorders
US11013750B2 (en) 2017-01-20 2021-05-25 Aurin Biotech Inc. Methods for treating and preventing nociceptive pain

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007270A (en) 1975-11-18 1977-02-08 American Cyanamid Company Complement inhibitors
US5030442A (en) 1987-03-30 1991-07-09 Liposome Technology, Inc. Non-crystalline minoxidil composition
DE4222534A1 (de) * 1992-07-09 1994-01-13 Behringwerke Ag Verwendung von Komplement-Inhibitoren zur Herstellung eines Arzneimittels zur Prophylaxe und Therapie von entzündlichen Darm- und Hauterkrankungen sowie Purpura
US5434185A (en) 1993-05-17 1995-07-18 The University Of Kentucky Research Foundation Method for inhibiting angiogenesis with aurintricarboxylic acid, its analogues or salts
US6770633B1 (en) * 1999-10-26 2004-08-03 Immusol, Inc. Ribozyme therapy for the treatment of proliferative skin and eye diseases
EP1223950B1 (en) 1999-10-26 2006-01-04 Immusol, Inc. Ribozyme therapy for the treatment of proliferative eye diseases
US6538028B1 (en) * 2000-02-01 2003-03-25 Vanderbilt University Method for inhibiting complement activation
US8883856B2 (en) * 2000-02-28 2014-11-11 John Jackson Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
US20110189310A1 (en) 2008-10-08 2011-08-04 Cornell University Small molecule modulators of prongf uptake
US20130035392A1 (en) 2011-08-01 2013-02-07 Mcgeer Patrick L Selective inhibition of the membrane attack complex of complement and C3 convertase by low molecular weight components of the aurin tricarboxylic acid synthetic complex
US10966945B2 (en) 2011-08-01 2021-04-06 Aurin Biotech Inc. Selective inhibition of the membrane attack complex of complement by low molecular weight components of the aurin tricarboxylic synthetic complex
EP2872130A4 (en) * 2012-07-13 2016-06-22 Aurin Biotech Inc SELECTIVE INHIBITION OF COMPLEMENT AND C3 CONVERTASE MEMBRANE ATTACK COMPLEX BY LOW MOLECULAR WEIGHT COMPONENTS OF THE TRICARBOXYLIC PARAROSOLIC ACID SYNTHETIC COMPLEX

Similar Documents

Publication Publication Date Title
TWI794222B (zh) 組成物在製備治療睡眠障礙的藥劑的用途
US20140199413A1 (en) Melatonin and an antimicrobial or antibacterial agent for the treatment of acne
US20120064174A1 (en) Method for stimulating hair growth
Stephens et al. Pilot study of topical copper chlorophyllin complex in subjects with facial acne and large pores
CN110769817A (zh) 皮肤治疗方法、含类视黄醇的组合物及其递送系统
JP2016501236A5 (enExample)
TWI822674B (zh) 組成物在製備治療異位性皮膚炎的藥劑的用途
CA2893966C (en) Topical treatment of inflammatory skin conditions using a combination of aurin tricarboxylic, aurin quadracarboxylic and aurin hexacarboxylic acids
US20140271920A1 (en) Skin ointment formulation
US20200030398A1 (en) Skin care composition
US8936814B2 (en) Skin cream
JP6422737B2 (ja) ロキソプロフェンを配合する外用剤組成物
WO2016144196A1 (en) A pharmaceutical and/or cosmetic composition for treating skin diseases and damages, the process for preparing of the pharmaceutical and/or cosmetic composition and its use
CA2378563A1 (en) Compositions and methods for the treatment of skin disorders
JP6671832B2 (ja) ヒートショックタンパク質の発現誘導剤
KR20070000675A (ko) 녹두 추출물, 백급 추출물 및 승마 추출물을 포함하는조성물 및 이의 용도
EP1688145A1 (en) Methods and compositions for treating psoriasis
Visser Non-pharmacological management of atopic dermatitis, including emollients
MX343073B (es) 1,3-benzoxazol-2(3h)-onas novedosas y su uso como medicamentos y cosmeticos.
ES2577862B1 (es) Composición farmacéutica para su uso en el tratamiento de la psoriasis
WO2019132850A1 (en) Dermatologic and cosmetologic treatment compounds showing antiinflammatory and antipruritic characteristics having adjuvant interaction strontium salts and licorice combinations
SK1252022U1 (sk) Prírodný dermálny krém na citlivú, ekzematickú a dermatóznu pokožku
BR102018011185A2 (pt) formulações tópicas para a prevenção e tratamento de doenças do couro cabeludo e para indução do crescimento capilar
SK7615Y1 (sk) Liečivá masť na citlivú a suchú pleť s protizápalovým, protisvrbivým, dezinfekčným, hydratačným a vyživujúcim účinkom
SK8566Y1 (sk) Naturálny výživový krém na citlivú, starnúcu a suchú pleť